New Jersey Senator Cory Booker issued a report on April 10 noting that 10 big pharma and biotech companies have decided to use their windfalls from last year's tax reform legislation for stock buybacks and other investments rather than reducing the prices for their drugs.
On the same day, Pfizer Inc. and Amgen Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?